US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0992-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0991-2023
Class II · Moderate risk Terminated

potassium phosphate

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0990-2023
Class II · Moderate risk Terminated

norepinephrine

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. NDC 72196-8095-1 D-0988-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0985-2023
Class II · Moderate risk Terminated

oxyTOCIN

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0983-2023
Class II · Moderate risk Terminated

neostigmine 5 mg/5mL

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0982-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0980-2023
Class II · Moderate risk Terminated

oxyTOCIN 20 units added to 0.9% sodium chloride 1

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0976-2023
Class II · Moderate risk Terminated

vancomycin 1.5 g/250mL added to 5% dextrose

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-0968-2023